Next Article in Journal
Protein Carbonylation as a Reliable Read-Out of Urban Pollution Damage/Protection of Hair Fibers
Previous Article in Journal
A Green Tea Containing Skincare System Improves Skin Health and Beauty in Adults: An Exploratory Controlled Clinical Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cosmetics
Volume 9
Issue 5
10.3390/cosmetics9050097
cosmetics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Measurement of Stress Relief during Scented Cosmetic Product Application Using a Mood Questionnaire, Stress Hormone Levels and Brain Activation

by
Arielle Springer
1,*,†,
Laura Höckmeier
1,†,
Doris Schicker
1,2,
Stefan Hettwer
3 and
Jessica Freiherr
1,2,*
1
Sensory Analytics and Technology, Fraunhofer Institute for Process Engineering and Packaging IVV, Giggenhauser Straße 35, 85354 Freising, Germany
2
Department of Psychiatry and Psychotherapy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany
3
Rahn AG, Doerflistrasse 120, 8050 Zurich, Switzerland
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cosmetics 2022, 9(5), 97; https://doi.org/10.3390/cosmetics9050097
Submission received: 5 August 2022 / Revised: 7 September 2022 / Accepted: 9 September 2022 / Published: 15 September 2022
Browse Figures
Review Reports Versions Notes

Abstract

:
Nowadays, consumers’ well-being plays a decisive role in the purchase of cosmetic products. Although factors influencing consumers’ well-being are very subjective, companies strive to develop their products in such a way that a positive effect is likely. Therefore, methods are required to objectively explore and scientifically prove the product’s performance on humans. In this placebo-controlled study, a method was developed to evaluate relaxation or stress relief associated with one olfactory ingredient of a cosmetic product (face cream). Our experimental protocol included product testing in 25 healthy females, while an emotion questionnaire, analysis of saliva samples regarding the concentration of the hormones cortisol and α-amylase and mobile EEG measurement for quantification of the alpha brain waves before and after stress induction were conducted. It was shown that with this experimental design, the sample with the ingredient produced significant stress relief, as evidenced by significantly less negative emotion, significantly lowered cortisol levels and showed a trend towards a significant increase in alpha activity compared to placebo application. Our data provide evidence that this method is suitable for analyzing the differences between the two samples. In the future, this method can be utilized in the current or a further optimized form to evaluate the psychophysiological effects of cosmetic products on humans.

1. Introduction

Especially in times of crisis, such as the pandemic, the general stress level of consumers increases [1,2]. To relax, many people enjoy wellness experiences using cosmetic products such as oils, bubble baths and scented shower gels or body lotions, especially with stress relieving properties communicated via marketing claims [3,4,5]. Whether the relaxing effect is caused by the product or the relaxing environment is not always clear. Therefore, consumers, authorities and companies along the value chain request better scientific evidence of the effects of cosmetic products on humans [6,7].
Aroma components of natural products have been used for mental, spiritual and physical healing since the beginning of recorded history. The best-known relaxing fragrance, lavender, has already been shown to induce a calming effect in numerous studies; for example, salivary stress markers are reduced [8], sleep quality is enhanced [9] and anxiety is reduced [10], to name just a few out of numerous examples. The aromatic components of the relatively unknown plant Myrothamnus flabellifolia can also have a relaxing effect on humans. These shrubs can resurrect in alternating humidity conditions after almost complete desiccation. Extracts from this plant have already been proposed in the literature for use in cosmetic products, for example, due to polyphenols [11,12,13], their healing [14] or their fibroblast-activating effect [15]. Their antimicrobial and antiviral effect was also proven [16,17]. Myrothamnus flabellifolia leaves produce resins and essential oils whose main components are trans-pinocarveol and pinocarvone, which have, respectively, a tart and minty odor [14,16,18]. Other aroma components identified include 𝛼-pinene, limonene, linalool and ß-selinene [14,19]. Kessler et al. (2014) showed that pinocarveol is a potent modifier of GABAA receptor function [20]. Since the GABAergic system is highly involved in the regulation of anxiety, this could be a possible explanation for the anxiolytic effect of this aroma component [21,22]. It was further established that the stimulation of the receptors in the nose through fragrance inhalation exerts various psychophysiological effects on human beings [23,24], including effects on mood [25] or hormone levels [26]. For a detailed systematic review of psychophysiological responses to odors, see Loos et al. [27].
The psychophysiological reaction to an odor can be measured via EEG recordings placed on the surface of the scalp [28,29]. Different studies have demonstrated the applicability of EEG measurements to study the influence of scents on brain activity [30,31].
The EEG power spectrum is classified into different frequency bands such as gamma (30–44 Hz), beta (13–30 Hz), alpha (7.5–13 Hz), theta (4–8 Hz) and delta (1–4 Hz) frequency bands, and each band is correlated with different features of brain states. In the common awake state with eyes open, gamma and beta waves are dominant. When dozing or in a state of relaxation, alpha activity increases [32]. Theta waves occur during the transition from the conscious state toward sleepiness and are attributed to access to unconscious material, creative inspiration and deep meditation [33]. During deep sleep, delta waves have a high proportion [31]. In particular, alpha waves are associated with mental coordination, calmness, integration and learning states of the brain [34,35,36]. An increase in alpha activity is highly correlated with a comfortable state in humans after inhaling lavender oil [37] and a relaxed state after exposure to neroli and grapefruit oil [38]. Sowndhararajan and Kim (2016) have already provided a comprehensive overview of previous studies in the field [39].
Measurement with conventional EEG shows numerous disadvantages, such as the high costs of the devices, the time-consuming attachment of the electrodes and the distraction of the subjects due to the cables and attached electrodes. Further, the association with medical equipment could trigger negative effects in the participants, which may not be transferable to a relaxing and mindful practice and could possibly falsify the results. Therefore, an alternative method of measuring brain activity is required in which these negative effects are reduced, and the benefits of the measurement method are maintained. One possibility would be to use a mobile EEG device with four electrodes that is significantly less expensive, is applied in a time-saving manner similar to a headband and is more comfortable and less invasive for the test person. Previous studies showed good applicability of mobile EEG devices regarding psychophysiological response measurements, but in those studies, mobile devices with more than 4, in particular, 14 electrodes, were utilized [40]. Further, with the help of those devices, brain response in a sports science context [41], in urban environments [42] or pathological processes such as epilepsy were monitored [43]. To date, within two publications, the scientific use of the Muse–portable EEG headband device with four electrodes was introduced [44,45]. Further, the system was used for the investigation of visual attention [46] or emotional well-being [47] but also for prediction of stroke severity [48]. However, due to their affordability, fast attachment and high wearing comfort, mobile EEGs have also been offered outside the scientific community as part of neurofeedback applications to improve sleep [43], concentration [49] or meditation [50,51], which proves the practicability of the system. Recently, it was confirmed that the emotional effect of cosmetics can be investigated using EEG and that stimuli arising from cosmetics can have an influence on the human brain [52,53]. In a previous study, the psychophysiological effects of cosmetics were shown [54], although other measuring methods were used, such as heartbeat and skin conductance measurements [55,56], facial electromyogram and mood questionnaires [57,58]. To the best of the authors’ knowledge, no literature is cited to date describing the use of a validated and standardized method for exploration of the psychophysiological effects of cosmetic products or ingredients using a mobile four-electrode EEG system.
Another stress marker is the production of stress hormones, e.g., cortisol and α-amylase. As Chrousos (2009) stated in a review, the main peripheral effectors of the stress system are glucocorticoids regulated by the hypothalamic–pituitary–adrenal (HPA) axis, and the catecholamines are norepinephrines and epinephrines regulated by the systemic and adrenomedullary sympathetic nervous systems [59]. Thus, through stress, the HPA axis is activated, and corticotropin-releasing hormones and adrenocorticotropic hormones are released, leading to an increased level of glucocorticoid cortisol. The analysis of salivary cortisol as a stress biomarker offers significant advantages over the analysis of blood cortisol, as the sample collection is non-invasive and more time- and cost-effective. The concentration of cortisol in saliva provides a valid and reliable reflection of unbound cortisol in blood [60]. Another biomarker of stress is the release of salivary α-amylase through the activation of the autonomic nervous system [61]. Previous research findings show a clear relationship between experiencing different stress situations and increasing salivary α-amylase levels [62,63]. Takai et al. (2004) examined both cortisol and α-amylase concentrations in saliva during stress induced by an unpleasant video and showed that α-amylase concentrations increased shortly after the onset of stress induction, while cortisol concentrations increased with a slight delay [64].
The psychological effect of an odor can also be perceived by the human subjects themselves and can be quantified using a questionnaire. For this purpose, various scales exist. The Positive and Negative Affect Schedule (PANAS) provides a way to briefly and easily determine the state of mind of individuals and examine positive (PA) and negative (NA) affect, each with 10 items. A high PA is a measure of a person’s enthusiasm, activity and alertness, while a low PA indicates sadness and lethargy. A high NA represents distress and unpleasurable engagement, while a low NA reflects calmness and serenity [65]. Yim et al. (2010) combined cortisol level measurement and PANAS after standardized stress induction in adults and children [66]. They showed stress increases salivary cortisol, lowers positive affect and raises negative affect. However, no correlation was found between the self-reported mood state (PA and NA) and the change in cortisol level. Another study found a correlation between a dampening of the cortisol rise, a reduction of state anxiety, a favorable change in mood profile and a reduction of non-verbal behavioral patterns that signal anxiety, motivational conflict and avoidance while using a cosmetic product [52]. Although research on stress reduction in relation to use of cosmetics or perfumed products is still in its early stages, recent results show that the application of a cosmetic cream enriched with essential oils should be considered as a stress resilience fostering strategy [52,67].
Already existing data indicate that the applicability of the methods for the evaluation of cosmetics and fragrances for the measurement of a psychophysiological effect is likely [52], but concrete evidence is missing. Therefore, we see a need to elaborate on this aspect with a reliable and reproducible experimental approach. Consequently, the aim of this study was to develop a method combining the PANAS questionnaire, mobile EEG measurement as well as analysis of saliva samples regarding the concentration of cortisol and α-amylase before and after experimental stress induction and to prove its applicability in a use case with and without an active ingredient. This research will enable a reliable standard for the objective scientific examination of the effectiveness of cosmetic products or ingredients in the future.

2. Materials and Methods

2.1. Sensory Evaluation of the Active Ingredient

To prove that a sensory perception of the active ingredient takes place, the fragrance was characterized by a trained sensory panel. The active ingredient was a Myrothamnus flabellifolia CO2 extract. Branches of the bush were harvested in wild pick in accordance with the South African Access and Benefit Sharing Regulations under the Nagoya Protocol. The project will support local communities and sustain the population of Myrothamnus flabellifolia bushes. The resulting oily extract was diluted in neutral oil (Caprylic/Capric Triglyceride) to standardize the extract to a concentration of 11.4% essential oils. However, it should be noted that the extract is a natural product with fluctuating content of essential oils. Due to the different growth conditions of each batch, the final content may vary. This extract was evaluated using a conventional aroma profile analysis by 12 trained testers according to DIN-Norm [68]. In the first step, a collection of descriptive attribute characteristic of the sample was created. From these attributes, the most characteristic five attributes were selected, and similar ones were summarized. In the second step, an intensity rating of the sample was determined with respect to the five selected attributes on a 10-point scale. We determined the mean and standard deviation for each attribute.

2.2. Method Development for Instrumental Measurement of Stress Relief

To objectively investigate and scientifically prove a cosmetic product’s performance on humans, we developed a method to evaluate the relaxation or stress relief associated with the odor of the complete product as well as an assessment of the pleasantness, arousal and emotional state of the consumers.
Ethical approval for this study protocol was obtained from the University Hospital at FAU Erlangen-Nürnberg prior to commencing tests (No. 75_20B). A hygiene concept was implemented specifically for this study in terms of a questionnaire, face masks, disinfection, keeping distance, and airing out the testing room due to the COVID-19 pandemic. The extract was proven safe in a comprehensive Toxicology and Safety Assessment Report on 17 December 2019 conducted at Rahn AG. All other ingredients are commonly used in cosmetic formulations and were evaluated as safe by DERMATEST (Münster, Germany) with a similar formulation on 16 June 2017.
Products with the active compound (AC) and without the active compound (placebo, PL) were randomly tested. Both formulations were perfumed with vanilla scent under the hypothesis that the intrinsic odor of the active ingredient could only be perceived subconsciously. The samples were identical in all cosmetically relevant characteristic parameters. Since there were no perceivable differences between the samples in terms of viscosity, we did not perform rheological tests. The samples were both filled in identical airless pump dispensers, meaning that the application volume of the cream was equal. Therefore, it can be assumed that all measured differences between the two samples were due to the active ingredient and that the matrix had no influence on the test result. Table 1 shows the characterization of the samples.
The two samples were coded and tested in 25 healthy women. The subjects were unaware of the sample they were receiving. Each subject received both samples on two different days, with the order of samples pseudorandomized across subjects. The subjects were between 18 and 50 years old (mean: 25.7 years, SD: 4.1 years), reported normal taste and smell sensitivity, normal or corrected to normal vision, had no history of neurological or mental diseases, were not pregnant, not breastfeeding, not using drugs and had no symptoms of a SARS-CoV-2 infection. Four out of twenty-five subjects were smokers. The mental condition of the participants was examined using the Beck Depression Inventory (BDI, mean: 3.0, SD: 3.3, range: 0–14) and the Mini Mental State Examination (MMSE, mean: 29.6, SD: 0.7, range: 28–30). Odor identification performance was investigated using the Sniffin’ Sticks identification test (mean: 14.1, SD: 0.9, range: 12–16).
The implementation of the method included a stress induction block and a product testing block. As a preparatory step, the EEG band was adapted to the subject’s head and calibrated for 5 min. These data were only used to verify the functionality of the experimental setup and were not evaluated. In the stress induction block, stress was induced using images of the OASIS image database [69] over a period of 2.5 min. The images were chosen to be negative and of high emotional arousal. Two image sets with identical mean negativity and arousal levels were created, one for each testing session. After stress induction, brain responses were measured over a period of 5 min [70,71]. After this time, a saliva sample was obtained for the examination of α-amylase and cortisol [61,64], and the participant’s mood state was evaluated by the PANAS questionnaire [65,72]. Afterwards, in the odor testing block, the subjects applied a defined amount of the product or placebo to their cheeks and sensed with their eyes closed for one minute. Subsequently, we measured brain responses over a period of 5 min, and a saliva sample and a mood questionnaire were obtained and conducted again. The scheme of the experimental paradigm is shown in Figure 1.
EEG data were acquired with the EEG headband Muse 2 (IntraXon, Toronto, ON, Canada) [70] and processed with Mind Monitor [73] which uses Fast Fourier Transformation to compute the power spectral densities for the alpha, beta, gamma, delta and theta frequency bands and calculates the absolute band powers using the logarithm of the sum of the respective power spectral densities. We averaged the alpha band powers across the two TP electrodes. After 5 min of recording, we cut off the first and last minute to correct for influences of the experimenter and the external surrounding of the participant. Then, we calculated the mean of the resulting three minutes per subject and subsession. To examine the effect of sample application on alpha activity, we conducted a rm ANOVA with time (before and after product application) and sample (AC and PL) as factors. Twenty-four subjects were included in the analysis as one subject had to be excluded due to missing electrode contact.
Saliva samples were collected via Salivettes (Sarstedt, Nümbrecht, Germany) and were stored for later assessment at −30 °C after the laboratory session. They were analyzed at the Chair of Health Psychology at FAU Erlangen. The samples were centrifuged at 2000× g and 4 °C for 10 min. Cortisol concentrations were assessed in duplicate using the chemiluminescence immunoassay (CLIA, IBL International, Hamburg, Germany). The quantification of α-amylase levels was conducted using in-house enzyme kinetic assays, also in duplicate determinations with reagents from Roche Diagnostics (Mannheim, Germany). To examine the effect of AC vs. PL on the concentration of the stress hormones cortisol and 𝛼-amylase in the saliva, we performed rm ANOVAs with the factors time (before and after product application) and sample (AC and PL). Due to missing data on hormone concentration, we had to exclude one subject from cortisol analysis and two subjects from the α-amylase analysis.
The PANAS questionnaire consisted of 10 positive and 10 negative items, wherein each item was rated from 1 (very slightly or not at all) to 5 (extremely) [65]. For a detailed description, please refer to Breyer and Blume (2016) [72]. The Positive Affect Score (sum of all positive items) and the Negative Affect Score (sum of all negative items) were calculated for each subject. Both scores ranged from a minimum of 5 (low affect) to 50 (high affect). Thus, both scores were calculated for each subject before and after product application, analogously for the AC and PL. To examine the effect of AC vs. PL on the positive and negative affect scores of PANAS, we performed rm ANOVAs with the factors time (before and after product application) and sample (AC and PL).
Statistical analyses were conducted in JASP 0.16 [74] and Python 3.7.1 [75]. p-values of post hoc tests were adjusted using Holm correction [76].

3. Results

3.1. Sensory Aroma Evaluation

During the sensory aroma evaluation, the attributes acid-like, citrus-like, herb-like (dill-like, thyme-like, rosemary-like), fatty/oily and fir-like/conifer-like/resin-like were identified as most characteristic of the Myrothamnus flabellifolia extract. The attributes were rated on a scale from 0 to 10 (mean ± SD), with fir tree-like (7.25 ± 2.05) as the most dominant attribute, followed by citrus-like (6.00 ± 1.81), herb-like (5.92 ± 2.39), acid-like (3.75 ± 2.05) and fatty/oily (2.83 ± 1.47). These data provide evidence that the extract is orthonasally perceivable and a potential effect is possible. The results are shown in Figure 2.

3.2. Effects of AC Application on Mood

The evaluation of the mood questionnaire (see Table 2, Figure 3) established a trend towards a significant interaction of time and sample (p = 0.076) with an enhanced PA score after AC application (before: 23.9 ± 8.9, after: 25.7 ± 8.7) in contrast to PL application (before: 24.0 ± 7.3, after: 23.6 ± 8.0). The main effects were not significant (time: p = 0.385, sample: p = 0.358). There was no significant interaction concerning the NA score (p = 0.398). However, there was a significant main effect of time (p < 0.001) due to significantly decreased NA scores after product application of both samples (AC before: 16.0 ± 6.2, after: 11.2 ± 1.9; PL before: 17.2 ± 6.6, after: 11.4 ± 1.9).

3.3. Effect of AC Application on Stress Hormones

For the biomarker cortisol we established a significant interaction effect of time and sample (p = 0.017, Table 3, Figure 4), resulting from a significantly decreased concentration of salivary cortisol after AC application (before: 6.32 ± 4.17, after: 5.89 ± 3.65, p = 0.042) in contrast to PL application that led to no significant change in cortisol concentration (before: 6.17 ± 4.01, after: 6.50 ± 3.91, p = 1.000). For α-amylase, there was neither a significant interaction effect (p = 0.112) nor significant main effects (time: p = 0.763, sample: p = 0.801, Table 3).

3.4. Effects of AC application on Brain Alpha Waves

Brain activity measured with EEG showed a trend towards a significant interaction effect of time and sample on the alpha-activity in the temporal brain regions (see Table 4) due to higher alpha activity after AC application in contrast to PL application (before: AC 0.886 ± 0.312, PL 0.910 ± 0.278; after: AC 0.881 ± 0.328, PL 0.861 ± 0.284). The main effects for time and sample were non-significant.
The EEG data depicted in Figure 5 show a curve in which the alpha waves of both placebo and active started at a higher point. This indicates relaxation, although the stress induction took place in direct temporal proximity. It can be assumed that the brain of the subjects needed a certain time to process the stress induction and to react with a change of activity, similar to stress hormones. It can be seen that at −2 min, the alpha value was at its lowest, and thus, the stress level was at its highest, confirming that a waiting time of 5 min was suitable for this study. Afterwards, the application of the product took place. In the progression of the placebo curve, it is visible that from the measuring point at −2 min and the measuring point at +2 min, the absolute value changed slightly, therefore the placebo had barely any influence on the test persons. During application of the active compound, alpha activity increased between the time points −2 min to +2 min, indicating relaxation due to the application of the cream.

4. Discussion

The aim of this research was to establish an experimental paradigm to evaluate the stress-relieving effects of a cosmetic product using the combination of a mood questionnaire, salivary stress hormone levels and brain activity.
Sensory aroma evaluation (Section 3.1) describes the major aroma components of the product and is in line with with already published data [16,19]. One major compound in the essential oil of Myrothamnus flabellifolia is trans-pinocaveol, which is associated with a woody–balsamic aroma. Another major component is limonene, which may be responsible for the citrus-like odor [16,77].
Our results of the PANAS analysis (Section 3.2) indicate that overall positive feelings increased among subjects, while negative feelings were reduced when the AC sample was used. As such, the odor of Myrothamnus flabellifolia affected subjective reported feelings. Since odors are known for a strong connection to emotions and mood [78,79], it is feasible that the odor of the cosmetic product elicits this effect [80]. Data from the literature confirm that it is possible to measure a positive change in mood profile, as well as a reduction in anxiety and nonverbal avoidance behaviors, after using a specific cosmetic product containing essential oils [52].
Salivary stress hormone analysis (Section 3.3) indicated a clear increase in both α-amylase and cortisol levels after product application during PL application, while a clear decrease was visible during AC application compared with the data before application. It was previously shown that applying stress significantly increases the concentrations of the stress hormones cortisol and α-amylase [62,63,64]. On the other hand, stress hormones can be reduced or less increased by special therapies [81,82], including odor stimulation [83] or essential oil inhalation [84,85,86]. Our data indicate that stress hormone levels in the subjects decreased with the use of the AC sample. Therefore, the odor of essential oils in cosmetic products can also positively influence stress hormone concentrations.
The brain activation measurements (Section 3.4) showed a trend towards a significant increase in alpha activity after odor exposure to the AC sample containing the extract after an induction phase. In the literature, this effect was also described by the inhalation of other extracts and essential oils [38,39,40].
Based on the data of this use case, the application of the formulation with the active compound, namely essential oils of Myrothamnus flabellifolia, caused a considerable trend toward a significantly more positive mood, a significant decrease in the level of the stress hormone cortisol and a statistical trend for higher alpha activity in the temporal regions compared to the placebo. Myrothamnus flabellifolia is used in traditional medicine, for example, in Madagascar, to treat respiratory diseases, kidney problems, asthma or herpes simplex virus type 1, amongst others. The essential oil contains biologically active compounds with antiviral, antimicrobial and fungicidal activity [16,17,20]. We were able to show that the essential oil also has a psychophysiological effect, namely a stress-relieving effect, that can be achieved if it is used in cosmetic products, particularly in face creams. These properties, in addition to other characteristics such as the presence of polyphenols [11,12,13] or a fibroblast-activating effect [15], make the essential oil of Myrothamnus flabellifolia a promising cosmetic ingredient.
Overall, the evaluation of the values of PANAS, the salivary hormone concentrations and the brain waves with the EEG headband showed high interpretability of the results. Thus, it could be proven that the study design, the method including the mobile EEG measurement coupled with the stress hormone analysis and the evaluation of the mood questionnaire were suitable to investigate the performance of two cosmetic products in comparison.
However, there are a few limitations of the current study. Stress induction was performed using pictures from various stressful life situations [68]. Nevertheless, the stress response to real situations might be different and other stress factors were not tested. The exposure of the subjects to the product took place in a calm and concentration-enhancing environment, which could differ from the practice and daily routines of consumers.
A complete calibration of the measured effects with the concentration of the active ingredient was not yet possible with the data. Therefore, the measured effect can only be confirmed for the used concentration of 3% Myrothamnus flabellifolia extract. It should be taken into account that the percentage of essential oils in the extract can vary between 10 and 15% and, accordingly, at a feed concentration of 3%, can range from 0.3 g to 0.45 g per 100 g of product. It is recommended to adjust the input concentration of the extract to the essential oil content of the respective batch or to standardize the extract. Additionally, the effect can only be confirmed for the batch tested, as various metabolites may be produced by different factors during plant growth [87].
Furthermore, one difference between the AC and PL variants, apart from the active content, was the content of water and triglycerides, respectively. Since the extract was diluted with triglycerides, the main component of the 3% activity extract was a component of the oil phase. In the PL sample, this 3% oil phase was absent, and the water phase was increased by 3%. This could have an effect on viscosity and spreadability, and thus overall skin feel [88]. The authors are not aware of any data describing the influence of a small deviation of the emulsion phases of approx. 3%. For future work, we recommend quantifying skin feel / tactile perception using both physical and psychological methods and enabling predictability through correlation with ingredients in the formulation. Additionally, the altered polarity due to the oil phase difference could also change the perception of the aroma components. However, since essential oils are more soluble in the oil phase, increasing the oil phase would hinder their liberation [89]. According to the knowledge of the authors, no study was found in the literature describing the impact of such a small change in the oil phase on human perception. In addition to the proportion of the oil phase, the viscosity, the type and amount of emulsifiers and the composition of the oil phase, e.g. unsaturated fatty acids or the chain length of the emollients, may also play a role in the perception of the scents. This can also be investigated in future work. Based on current experience, we recommend balancing the actives in the placebo with an ingredient of similar polarity for further studies.
Additionally, the vanilla scent was used to mask the essential oil in both variants AC and PL. While this provides comparability, the effect of the extract demonstrated in this approach could be a synergy between vanilla fragrance and the essential oil components [90]. Even though research on synergistic fragrance components in cosmetics is still in its early stages, this could be investigated more deeply in future work.
While this entire method can be applied to support claims about well-being and consumer acceptance of active ingredients or products, the effectiveness of each individual cosmetic product must be scientifically proven. As the number of study participants in this study was rather low and significant effects were not established for all of the investigated parameters, additional proof on finished cosmetic products with the active ingredient is advised. We recommend a panel size of 25 or larger for similar studies. Further studies need to be conducted to explore the transferability of the results to real life or other product categories. For example, the authors suggest investigating whether these or improved methods can be applied to rinse-off cosmetics such as shower gels or bath products. These products present challenges as they spend less time directly on the skin than leave-on products, yet the fragrances are more diffused in the air due to contact with warm water or steam. This could lead to dilution effects, but also to an increase in volatility.
Regardless of the used product, the proven effects can only be achieved if the application conditions of this study are followed exactly. Therefore, conditions to achieve the proved effectiveness should be stated on the label to guarantee correct use of the product according to the claims regulation currently in force. Additionally, it is recommended to determine the quantitative connection between signal intensity of the measurements and well-being in future research. This will provide a dose-response relationship between active ingredient concentration and the psychophysiological effects and enable the use of the ingredient in other concentrations.

5. Conclusions

The use of odors in cosmetic products to support consumer well-being is becoming increasingly popular, while at the same time, higher scientific standards are required to demonstrate effectiveness. Therefore, a method was developed combining stress induction with measurement of alpha waves of the brain, stress biomarkers in the saliva and mood using a questionnaire before and after exposure to products with and without active ingredients. The method was proved suitable for documenting the stress relieving effect of an active ingredient in a cosmetic product compared to a placebo. Significant results were achieved in this use case for some parameters. Further work is necessary to improve the transferability to practice.

Author Contributions

Conceptualization, J.F.; methodology, L.H., D.S., S.H. and J.F.; software, D.S.; validation, J.F.; formal analysis, L.H., D.S. and J.F.; investigation, L.H.; resources, S.H.; data curation, L.H., D.S. and J.F.; writing—original draft preparation, A.S., L.H. and D.S.; writing—review and editing, A.S., D.S., S.H. and J.F.; visualization, A.S.; supervision, J.F.; project administration, L.H.; funding acquisition, J.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Rahn AG Zürich, Switzerland. The project number was AS/5048/19. This work was further supported by the German Academic Scholarship Foundation to D.S., as well as the Initiative Campus of the Senses, a project with the financial support of the Bavarian Ministry of Economic Affairs, Regional Development and Energy (StMWi) and the Fraunhofer Society.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of University Hospital at FAU Erlangen-Nürnberg (protocol code 75_20B, date of approval 19 October 2020).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Not applicable.

Acknowledgments

We thank the volunteers for their participation in the measurements. We would also like to thank the technicians who prepared and performed the study. Additionally, we would like to thank Sally Arnhardt for the preparation of the methodology figure. We would like to thank Rahn AG for providing the samples for the use case. The present work was performed in (partial) fulfillment of the requirements for obtaining the degree “Dr. rer. biol. hum.” from FAU Erlangen-Nürnberg for D.S. and A.S.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Correction Statement

This article has been republished with a minor correction to the Acknowledgments. The present work was performed in (partial) fulfillment of the requirements for obtaining the degree "Dr. rer. biol. hum." from FAU Erlangen-Nürnberg for D.S. and A.S. This change does not affect the scientific content of the article.

References

  1. Zhang, Y.; Ma, Z.F. Impact of the COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province, China: A cross-sectional study. Int. J. Environ. Res. Public Health 2020, 17, 2381. [Google Scholar] [CrossRef] [PubMed]
  2. Mazza, C.; Ricci, E.; Biondi, S.; Colasanti, M.; Ferracuti, S.; Napoli, C.; Roma, P. A nationwide survey of psychological distress among Italian people during the COVID-19 pandemic: Immediate psychological responses and associated factors. Int. J. Environ. Res. Public Health 2020, 17, 3165. [Google Scholar] [CrossRef]
  3. Javeria, S.; Suki, N.M. Perceptions creating stress in cosmetics consumers: Analysis during COVID-19 pandemic in Pakistan. J. Cardiovasc. Dis. Res. 2021, 12, 135–139. [Google Scholar]
  4. Lee, J.; Kwon, K.H. The Significant Value of Sustainable Cosmetics Fragrance in the Spotlight After COVID-19. J. Cosmet. Dermatol. 2022. [Google Scholar] [CrossRef] [PubMed]
  5. Russo, M.Z. The Role of Cosmetics During and after the Pandemic Era; Euro Cosmetics: Munich, Germany, 2020. [Google Scholar]
  6. Available online: https://www.bvl.bund.de/DE/Arbeitsbereiche/03_Verbraucherprodukte/01_Aufgaben/06_Kosmetik/bgs_Kosmetik_node.html (accessed on 2 September 2022).
  7. Available online: https://www.oekotest.de/kosmetik-wellness/Wie-Hersteller-die-Wirksamkeit-ihrer-Kosmetik-belegen-oder-auch-nicht-_109535_1.html (accessed on 2 September 2022).
  8. Toda, M.; Morimoto, K. Effect of lavender aroma on salivary endocrinological stress markers. Arch. Oral Biol. 2008, 53, 964–968. [Google Scholar] [CrossRef] [PubMed]
  9. Hirokawa, K.; Nishimoto, T.; Taniguchi, T. Effects of lavender aroma on sleep quality in healthy Japanese students. Percept. Mot. Ski. 2012, 114, 111–122. [Google Scholar] [CrossRef]
  10. Kutlu, A.K.; Yılmaz, E.; Çeçen, D. Effects of aroma inhalation on examination anxiety. Teach. Learn. Nurs. 2008, 3, 125–130. [Google Scholar] [CrossRef]
  11. Bentley, J.; Moore, J.P.; Farrant, J.M. Metabolomic profiling of the desiccation-tolerant medicinal shrub Myrothamnus flabellifolia indicates phenolic variability across its natural habitat: Implications for tea and cosmetics production. Molecules 2019, 24, 1240. [Google Scholar] [CrossRef]
  12. Bentley, J.; Olsen, E.K.; Moore, J.P.; Farrant, J.M. The phenolic profile extracted from the desiccation-tolerant medicinal shrub Myrothamnus flabellifolia using Natural Deep Eutectic Solvents varies according to the solvation conditions. Phytochemistry 2020, 173, 112323. [Google Scholar] [CrossRef]
  13. Bentley, J.; Moore, J.P.; Farrant, J.M. Metabolomics as a complement to phylogenetics for assessing intraspecific boundaries in the desiccation-tolerant medicinal shrub Myrothamnus flabellifolia (Myrothamnaceae). Phytochemistry 2019, 159, 127–136. [Google Scholar] [CrossRef]
  14. Cheikhyoussef, A.; Summers, R.W.; Kahaka, G.K. Qualitative and quantitative analysis of phytochemical compounds in Namibian Myrothamnus flabellifolius. Int. Sci. Technol. J. Namib. 2015, 5, 71–83. [Google Scholar]
  15. Biscaro, R.C.; Mussi, L.; Sufi, B.; Padovani, G.; Junior, F.B.C.; Magalhães, W.V.; Di Stasi, L.C. Modulation of autophagy by an innovative phytocosmetic preparation (Myrothamnus flabelifolia and Coffea arabica) in human fibroblasts and its effects in a clinical randomized placebo-controlled trial. J. Cosmet. Dermatol. 2022. [Google Scholar] [CrossRef] [PubMed]
  16. Viljoen, A.M.; Klepser, M.E.; Ernst, E.J.; Keele, D.; Roling, E.; Van Vuuren, S.; Demirci, B.; Baser, K.H.C.; van Wyk, B.-E.; Jäger, A.K. The composition and antimicrobial activity of the essential oil of the resurrection plant Myrothamnus flabellifolius. S. Afr. J. Bot. 2002, 68, 100–105. [Google Scholar] [CrossRef]
  17. Gescher, K.; Kühn, J.; Lorentzen, E.; Hafezi, W.; Derksen, A.; Deters, A.; Hensel, A. Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration. J. Ethnopharmacol. 2011, 134, 468–474. [Google Scholar] [CrossRef] [PubMed]
  18. Nicoletti, M.; Maggi, F.; Papa, F.; Vittori, S.; Quassinti, L.; Bramucci, M.; Lupidi, G.; Petrelli, D.; Vitali, L.A.; Ralaibia, E.; et al. In vitro biological activities of the essential oil from the ‘resurrection plant’Myrothamnus moschatus (Baillon) Niedenzu endemic to Madagascar. Nat. Prod. Res. 2012, 26, 2291–2300. [Google Scholar] [CrossRef] [PubMed]
  19. Chagonda, L.S.; Makanda, C.; Chalchat, J.-C. Essential Oils of Four Wild and Semi-Wild Plants from Zimbabwe: Colospermum mopane (Kirk ex Benth.) Kirk ex Leonard, Helichrysum splendidum (Thunb.) Less, Myrothamnus flabellifolia (Welw.) and Tagetes minuta L. J. Essent. Oil Res. 1999, 11, 573–578. [Google Scholar] [CrossRef]
  20. Kessler, A.; Sahin-Nadeem, H.; Lummis, S.C.R.; Weigel, I.; Pischetsrieder, M.; Buettner, A.; Villmann, C. GABAA receptor modulation by terpenoids from Sideritis extracts. Mol. Nutr. Food Res. 2014, 58, 851–862. [Google Scholar] [CrossRef]
  21. Hartley, N.; McLachlan, C.S. Aromas Influencing the GABAergic System. Molecules 2022, 27, 2414. [Google Scholar] [CrossRef]
  22. Nuss, P. Anxiety disorders and GABA neurotransmission: A disturbance of modulation. Neuropsychiatr. Dis. Treat. 2015, 11, 165. [Google Scholar]
  23. Herz, R.S. Aromatherapy facts and fictions: A scientific analysis of olfactory effects on mood, physiology and behavior. Int. J. Neurosci. 2009, 119, 263–290. [Google Scholar] [CrossRef]
  24. Angelucci, F.L.; Silva, V.V.; Dal Pizzol, C.; Spir, L.G.; Praes, C.E.; Maibach, H. Physiological effect of olfactory stimuli inhalation in humans: An overview. Int. J. Cosmet. Sci. 2014, 36, 117–123. [Google Scholar] [CrossRef]
  25. Herz, R.S. Influences of odors on mood and affective cognition. In Olfaction, Taste and Cognition; Rouby, C., Schaal, B., Dubois, D., Gervais, R., Holley, A., Eds.; Cambridge University Press: Cambridge, NY, USA, 2002; pp. 160–177. [Google Scholar]
  26. Schiffman, S.S.; Sattely-Miller, E.A.; Suggs, M.S.; Graham, B.G. The effect of pleasant odors and hormone status on mood of women at midlife. Brain Res. Bull. 1995, 36, 19–29. [Google Scholar] [CrossRef]
  27. Loos, H.M.; Schreiner, L.; Karacan, B. A systematic review of physiological responses to odours with a focus on current methods used in event-related study designs. Int. J. Psychophysiol. 2020, 158, 143–157. [Google Scholar] [CrossRef] [PubMed]
  28. Diego, M.A.; Jones, N.A.; Field, T.; Hernandez-Reif, M.; Schanberg, S.; Kuhn, C.; McAdam, V.; Galamaga, R.; Galamaga, M. Aromatherapy positively affects mood, EEG patterns of alertness and math computations. Int. J. Neurosci. 1998, 96, 217–224. [Google Scholar] [CrossRef]
  29. Field, T.; Diego, M.; Hernandez-Reif, M.; Cisneros, W.; Feijo, L.; Vera, Y.; Gil, K.; Grina, D.; Claire He, Q. Lavender fragrance cleansing gel effects on relaxation. Int. J. Neurosci. 2005, 115, 207–222. [Google Scholar] [CrossRef]
  30. Skoric, M.K.; Ivan Adamec, I.; Jerbić, A.B.; Gabelić, T.; Hajnšek, S.; Habek, M. Electroencephalographic response to different odors in healthy individuals: A promising tool for objective assessment of olfactory disorders. Clin. EEG Neurosci. 2015, 46, 370–376. [Google Scholar] [CrossRef] [PubMed]
  31. Sowndhararajan, K.; Cho, H.; Yu, B.; Kim, S. Effect of olfactory stimulation of isomeric aroma compounds, (+)-limonene and terpinolene on human electroencephalographic activity. Eur. J. Integr. Med. 2015, 7, 561–566. [Google Scholar] [CrossRef]
  32. Teplan, M. Fundamentals of EEG measurement. Meas. Sci. Rev. 2002, 2, 1–11. [Google Scholar]
  33. Sanei, S.; Chambers, J.A. EEG Signal Processing; John Wiley & Sons: Hoboken, NJ, USA, 2013. [Google Scholar]
  34. Klimesch, W.; Schmike, H.; Pfurtscheller, G. Alpha frequency cognitive load and memory performance. Brain Topogr. 1993, 5, 241–251. [Google Scholar] [CrossRef]
  35. Basar, E. A review of alpha activity in integrative brain function: Fundamental physiology, sensory coding, cognition and pathology. Int. J. Psychophysiol. 2012, 86, 1–24. [Google Scholar] [CrossRef]
  36. Kim, S.C.; Lee, M.H.; Jang, C.; Kwon, J.W.; Park, J.W. The effect of alpha rhythm sleep on EEG activity and individuals’ attention. J. Phys. Ther. Sci. 2013, 25, 1515–1518. [Google Scholar] [CrossRef] [PubMed]
  37. Masago, R.; Matsuda, T.; Kikuchi, Y.; Miyazaki, Y.; Iwanaga, K.; Harada, H.; Katsuura, T. Effects of inhalation of essential oils on EEG activity and sensory evaluation. J. Physiol. Anthropol. 2000, 19, 35–42. [Google Scholar] [CrossRef] [PubMed]
  38. Iijima, M.; Nio, E.; Nashimoto, E.; Iwata, M. Effects of aroma on the autonomic nervous system and brain activity under stress conditions. Auton. Neurosci. 2007, 135, 97–98. [Google Scholar] [CrossRef]
  39. Sowndhararajan, K.; Kim, S. Influence of fragrances on human psychophysiological activity: With special reference to human electroencephalographic response. Sci. Pharm. 2016, 84, 724–751. [Google Scholar] [CrossRef] [PubMed]
  40. Balart-Sánchez, S.A.; Vélez-Pérez, H.; Rivera-Tello, S.; Gómez-Velázquez, F.R.; González-Garrido, A.A.; Romo-Vázquez, R. A step forward in the quest for a mobile EEG-designed epoch for psychophysiological studies. Biomed. Eng./Biomed. Tech. 2019, 64, 655–667. [Google Scholar] [CrossRef] [PubMed]
  41. Mancevska, S.; Gligoroska, J.P.; Todorovska, L.; Dejanova, B.; Petrovska, S. Psychophysiology and the sport science. Res. Phys. Educ. Sport Health 2016, 5, 101–105. [Google Scholar]
  42. Mavros, P.; Austwick, M.Z.; Smith, A.H. Geo-EEG: Towards the use of EEG in the study of urban behaviour. Appl. Spat. Anal. Policy 2016, 9, 191–212. [Google Scholar] [CrossRef]
  43. Askamp, J.; van Putten, M.J.A.M. Mobile EEG in epilepsy. Int. J. Psychophysiol. 2014, 91, 30–35. [Google Scholar] [CrossRef]
  44. Krigolson, O.E.; Williams, C.C.; Norton, A.; Hassall, C.D.; Colino, F.L. Choosing MUSE: Validation of a low-cost, portable EEG system for ERP research. Front. Neurosci. 2017, 11, 109. [Google Scholar] [CrossRef]
  45. Krigolson, O.E.; Hammerstrom, M.R.; Abimbola, W.; Trska, R.; Wright, B.W.; Hecker, K.G.; Binsted, G. Using Muse: Rapid mobile assessment of brain performance. Front. Neurosci. 2021, 15, 634147. [Google Scholar] [CrossRef]
  46. Krigolson, O.E.; Williams, C.C.; Colino, F.L. Using portable EEG to assess human visual attention. In Proceedings of the International Conference on Augmented Cognition, Vancouver, Canada, 9–14 July 2017; Springer: Cham, Switzerland, 2017. Available online: http://2017.hci.international/ac (accessed on 2 September 2022).
  47. Herman, K.; Ciechanowski, L.; Przegalińska, A. Emotional well-being in urban wilderness: Assessing states of calmness and alertness in informal green spaces (IGSs) with muse—Portable EEG headband. Sustainability 2021, 13, 2212. [Google Scholar] [CrossRef]
  48. Wilkinson, C.M.; Burrell, J.I.; Kuziek, J.W.P.; Thirunavukkarasu, S.; Buck, B.H.; Mathewson, K.E. Predicting stroke severity with a 3-min recording from the Muse portable EEG system for rapid diagnosis of stroke. Sci. Rep. 2020, 10, 18465. [Google Scholar] [CrossRef] [PubMed]
  49. He, J.; Liu, D.; Wan, Z.; Hu, C. A noninvasive real-time driving fatigue detection technology based on left prefrontal Attention and Meditation EEG. In Proceedings of the 2014 International Conference on Multisensor Fusion and Information Integration for Intelligent Systems (MFI), Beijing, China, 28–29 September 2014. [Google Scholar]
  50. Purnamasari, P.D.; Fernandya, A. Real time EEG-based stress detection and meditation application with K-nearest neighbor. In Proceedings of the 2019 IEEE R10 Humanitarian Technology Conference (R10-HTC), Depok, Indonesia, 12–14 November 2019; p. 47129. [Google Scholar]
  51. Sravanth, K.R.; Peddi, A.; Sagar, G.S.; Gupta, B.; Chakraborty, C. Comparison of Attention and Meditation based mobile applications by using EEG signals. In Proceedings of the 2018 Global Wireless Summit (GWS), Chiang Rai, Thailand, 25–28 November 2018. [Google Scholar]
  52. Rizzi, V.; Gubitosa, J.; Fini, P.; Cosma, P. Neurocosmetics in Skincare—The Fascinating World of Skin–Brain Connection: A Review to Explore Ingredients, Commercial Products for Skin Aging, and Cosmetic Regulation. Cosmetics 2021, 8, 66. [Google Scholar] [CrossRef]
  53. Gabriel, D.; Merat, E.; Jeudy, A.; Cambos, S.; Chabin, T.; Giustiniani, J.; Haffen, E. Emotional Effects Induced by the Application of a Cosmetic Product: A Real-Time Electrophysiological Evaluation. Appl. Sci. 2021, 11, 4766. [Google Scholar] [CrossRef]
  54. Nozawa, A.; Uchida, M. Characterization of preference for viscosity and fragrance of cosmetic emulsions by autonomous nervous system activity. In Proceedings of the 2009 ICCAS-SICE, Fukuoka, Japan, 18–21 August 2009. [Google Scholar]
  55. Barkat, S.; Thomas-Danguin, T.; Bensafi, M.; Rouby, C.; Sicard, G. Odor and color of cosmetic products: Correlations between subjective judgement and autonomous nervous system response. Int. J. Cosmet. Sci. 2003, 25, 273–283. [Google Scholar] [CrossRef] [PubMed]
  56. Ohira, H.; Hirao, N. Analysis of skin conductance response during evaluation of preferences for cosmetic products. Front. Psychol. 2015, 6, 103. [Google Scholar] [CrossRef]
  57. Abriat, A.; Barkat, S.; Bensafi, M.; Rouby, C.; Guillou, V. Emotional and psychological effects of fragrance in men’s skin care. Int. J. Cosmet. Sci. 2005, 27, 300. [Google Scholar] [CrossRef]
  58. Abriat, A.; Barkat, S.; Bensafi, M.; Rouby, C.; Fanchon, C. Psychological and physiological evaluation of emotional effects of a perfume in menopausal women. Int. J. Cosmet. Sci. 2007, 29, 399–408. [Google Scholar] [CrossRef]
  59. Chrousos, G.P. Stress and disorders of the stress system. Nat. Rev. Endocrinol. 2009, 5, 374–381. [Google Scholar] [CrossRef]
  60. Kirschbaum, C.; Hellhammer, D.H. Salivary cortisol in psychoneuroendocrine research: Recent developments and applications. Psychoneuroendocrinology 1994, 19, 313–333. [Google Scholar] [CrossRef]
  61. Nater, U.M.; Rohleder, N. Salivary α-amylase as a non-invasive biomarker for the sympathetic nervous system: Current state of research. Psychoneuroendocrinology 2009, 34, 486–496. [Google Scholar] [CrossRef] [PubMed]
  62. Skosnik, P.D.; Chatterton, R.T.; Swisher, T.; Park, S. Modulation of attentional inhibition by norepinephrine and cortisol after psychological stress. Int. J. Psychophysiol. 2000, 36, 59–68. [Google Scholar] [CrossRef]
  63. Chatterton, R.T., Jr.; Vogelsong, K.M.; Lu, Y.C.; Hudgens, G.A. Hormonal responses to psychological stress in men preparing for skydiving. J. Clin. Endocri-Nology Metab. 1997, 82, 2503–2509. [Google Scholar] [CrossRef]
  64. Takai, N.; Yamaguchi, M.; Aragaki, T.; Eto, K.; Uchihashi, K.; Nishikawa, Y. Effect of psychological stress on the salivary cortisol and amylase levels in healthy young adults. Arch. Oral Biol. 2004, 49, 963–968. [Google Scholar] [CrossRef]
  65. Watson, D.; Clark, L.A.; Tellegen, A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J. Personal. Soc. Psychol. 1988, 54, 1063. [Google Scholar] [CrossRef]
  66. Yim, I.S.; Quas, J.A.; Cahill, L.; Hayakawa, C.M. Children’s and adults’ salivary cortisol responses to an identical psychosocial laboratory stress-or. Psychoneuroendocrinology 2010, 35, 241–248. [Google Scholar] [CrossRef]
  67. Sgoifo, A.; Carnevali, L.; Pattini, E.; Carandina, A.; Tanzi, G.; Del Canale, C.; Goi, P.; Giudice, M.B.D.F.D.; De Carne, B.; Fornari, M.; et al. Psychobiological evidence of the stress resilience fostering properties of a cosmetic routine. Stress 2021, 24, 53–63. [Google Scholar] [CrossRef]
  68. DIN 10961; Schulung von Prüfpersonen für Sensorische Prüfungen. Deutsches Institut für Normung e.V. Beuth Verlag GmbH: Berlin, Germany, 1996.
  69. Kurdi, B.; Lozano, S.; Banaji, M.R. Introducing the open affective standardized image set (OASIS). Behav. Res. Methods 2017, 49, 457–470. [Google Scholar] [CrossRef]
  70. Available online: https://choosemuse.com/ (accessed on 2 September 2022).
  71. Bird, J.J.; Manso, L.J.; Ribeiro, E.P.; Ekart, A.; Faria, D.R. A study on mental state classification using eeg-based brain-machine interface. In Proceedings of the 2018 International Conference on Intelligent Systems (IS), Funchal, Madeira Island, 25–27 September 2018. [Google Scholar]
  72. Breyer, B.; Bluemke, M. Deutsche Version der Positive and Negative Affect Schedule PANAS (GESIS Panel). Zusammenstellung sozialwissenschaftlicher Items und Skalen 2016. [Google Scholar] [CrossRef]
  73. Available online: https://mind-monitor.com/ (accessed on 2 September 2022).
  74. JASP. version 0.16.3; [Computer Software]; JASP Team: Amsterdam, The Netherlands, 2022. [Google Scholar]
  75. Python Software Foundation. Available online: https://www.python.org/ (accessed on 2 September 2022).
  76. Holm, S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979, 6, 65–70. [Google Scholar]
  77. Available online: https://www.fao.org/food/food-safety-quality/scientific-advice/jecfa/jecfa-flav/details/en/c/1402/ (accessed on 2 September 2022).
  78. Kontaris, I.; East, B.S.; Wilson, D.A. Behavioral and neurobiological convergence of odor, mood and emotion: A review. Front. Behav. Neurosci. 2020, 14, 35. [Google Scholar] [CrossRef] [PubMed]
  79. Chen, D.; Haviland-Jones, J. Rapid mood change and human odors. Physiol. Behav. 1999, 68, 241–250. [Google Scholar] [CrossRef]
  80. Kirk-Smith, M.D.; Van Toller, C.; Dodd, G.H. Unconscious odour conditioning in human subjects. Biol. Psychol. 1983, 17, 221–231. [Google Scholar] [CrossRef]
  81. Kaimal, G.; Ray, K.; Muniz, J. Reduction of cortisol levels and participants’ responses following art making. Art Ther. 2016, 33, 74–80. [Google Scholar] [CrossRef] [PubMed]
  82. Uedo, N.; Ishikawa, H.; Morimoto, K.; Ishihara, R.; Narahara, H.; Akedo, I.; Ioka, T.; Kaji, I.; Fukuda, S. Reduction in salivary cortisol level by music therapy during colonoscopic examination. Hepato-Gastroenterology 2004, 51, 451–453. [Google Scholar] [PubMed]
  83. Fukui, H.; Komaki, R.; Okui, M.; Toyoshima, K.; Kuda, K. The effects of odor on cortisol and testosterone in healthy adults. Neuroendocrinol. Lett. 2007, 28, 433–437. [Google Scholar] [PubMed]
  84. Kim, I.H.; Kim, C.; Seong, K.; Hur, M.H.; Lim, H.M.; Lee, M.S. Essential oil inhalation on blood pressure and salivary cortisol levels in prehypertensive and hypertensive subjects. Evid. -Based Complement. Altern. Med. 2012, 2012, 984203. [Google Scholar] [CrossRef]
  85. Watanabe, E.; Kuchta, K.; Kimura, M.; Rauwald, H.W.; Kamei, T.; Imanishi, J. Effects of bergamot (Citrus bergamia (Risso) Wright & Arn.) essential oil aromatherapy on mood states, parasympathetic nervous system activity, and salivary cortisol levels in 41 healthy females. Complement. Med. Res. 2015, 22, 43–49. [Google Scholar]
  86. Chaiyasut, C.; Sivamaruthi, B.S.; Wongwan, J.; Thiwan, K.; Rungseevijitprapa, W.; Klunklin, A.; Kunaviktikul, W. Effects of Litsea cubeba (Lour.) persoon essential oil aromatherapy on mood states and salivary cortisol levels in healthy volunteers. Evid. -Based Complement. Altern. Med. 2020, 2020, 4389239. [Google Scholar] [CrossRef]
  87. Figueiredo, A.C.; Barroso, J.G.; Pedro, L.G.; Scheffer, J.J. Factors affecting secondary metabolite production in plants: Volatile components and essential oils. Flavour Fragr. J. 2008, 23, 213–226. [Google Scholar] [CrossRef]
  88. Brummer, R.; Godersky, S. Rheological studies to objectify sensations occurring when cosmetic emulsions are applied to the skin. Colloids Surf. A Physicochem. Eng. Asp. 1999, 152, 89–94. [Google Scholar] [CrossRef]
  89. Doi, T.; Wang, M.; McClements, D.J. Emulsion-based control of flavor release profiles: Impact of oil droplet characteristics on garlic aroma release during simulated cooking. Food Res. Int. 2019, 116, 1–11. [Google Scholar] [CrossRef] [PubMed]
  90. Ryan, D.; Prenzler, P.D.; Saliba, A.J.; Scollary, G.R. The significance of low impact odorants in global odour perception. Trends Food Sci. Technol. 2008, 19, 383–389. [Google Scholar] [CrossRef]
Cosmetics 09 00097 g001
Figure 1. Experimental paradigm for stress induction and product testing phase.
Figure 1. Experimental paradigm for stress induction and product testing phase.
Cosmetics 09 00097 g001
Cosmetics 09 00097 g002
Figure 2. Conventional aroma profile of Myrothamnus flabellifolia extract evaluated by 12 trained testers.
Figure 2. Conventional aroma profile of Myrothamnus flabellifolia extract evaluated by 12 trained testers.
Cosmetics 09 00097 g002
Cosmetics 09 00097 g003
Figure 3. Changes (after versus before product application) for the positive and negative items of the Positive and Negative Affect Schedule (PANAS) for the samples placebo (PL) and active compound (AC) (mean ± SD). Note: (*) Trend towards statistical significance with p < 0.1. *** Significance with p < 0.001.
Figure 3. Changes (after versus before product application) for the positive and negative items of the Positive and Negative Affect Schedule (PANAS) for the samples placebo (PL) and active compound (AC) (mean ± SD). Note: (*) Trend towards statistical significance with p < 0.1. *** Significance with p < 0.001.
Cosmetics 09 00097 g003
Cosmetics 09 00097 g004
Figure 4. Change of salivary concentration of cortisol and α-amylase when compared after vs. before product application of the samples placebo (PL) and active compound (AC) (mean ± SD). Note: * Significance with p < 0.05.
Figure 4. Change of salivary concentration of cortisol and α-amylase when compared after vs. before product application of the samples placebo (PL) and active compound (AC) (mean ± SD). Note: * Significance with p < 0.05.
Cosmetics 09 00097 g004
Cosmetics 09 00097 g005
Figure 5. Alpha-activity in the frontal brain regions before and after the product application of the samples active compound (AC) and placebo (PL). Mean data from all subjects (N = 24) were pooled per minute and plotted as dots. The red line represents the product application. For the analysis, the blue areas between minute 2 and minute 4 were included, as this excluded any effects at the start of and towards the end of the measurement. At these times, interaction with the experimenter and the alarm clock took place and could have been an additional stress factor for the subjects.
Figure 5. Alpha-activity in the frontal brain regions before and after the product application of the samples active compound (AC) and placebo (PL). Mean data from all subjects (N = 24) were pooled per minute and plotted as dots. The red line represents the product application. For the analysis, the blue areas between minute 2 and minute 4 were included, as this excluded any effects at the start of and towards the end of the measurement. At these times, interaction with the experimenter and the alarm clock took place and could have been an additional stress factor for the subjects.
Cosmetics 09 00097 g005
Table 1. Characterization of the samples (AC = active compound, PL = placebo).
Table 1. Characterization of the samples (AC = active compound, PL = placebo).
ACPL
Ingredients (INCI)Water, Caprylic/Capric Triglyceride, Glyceryl Stearate Citrate, Cetearyl Alcohol, Phenoxyethanol, Sucrose Stearate, Carbomer, Caprylyl Glycol, Fragrance (Parfum), Xanthan Gum, Myrothamnus Flabellifolia Leaf/Stem Extract, Sodium HydroxideWater, Caprylic/Capric Triglyceride, Glyceryl Stearate Citrate, Cetearyl Alcohol, Phenoxyethanol, Sucrose Stearate, Carbomer, Caprylyl Glycol, Fragrance (Parfum), Xanthan Gum, Sodium Hydroxide
Active Compound3.0% Myrothamnus flabellifolia CO2-extract3.0% Water
pH-value5.85.8
Density [g/mL]0.9–1.00.9–1.0
Production date19 December 201919 December 2019
Shelf life [months]3636
Table 2. Results of rm ANOVA on the positive and negative affect with the factors time (before and after product and placebo application) and sample (AC and PL) (N = 25).
Table 2. Results of rm ANOVA on the positive and negative affect with the factors time (before and after product and placebo application) and sample (AC and PL) (N = 25).
EffectDFnumDFdenFp-Valueηp2
Positive Affect Score
Time1240.7830.3850.032
Sample1240.8780.3580.035
Time×Sample1243.4420.076 (*)0.125
Negative Affect Score
Time12427.615<0.001 ***0.535
Sample1241.6760.2080.065
Time×Sample1240.7410.3980.030
DFnum = degrees of freedom in numerator, DFden = degrees of freedom in denominator, F = noncentral F distribution, ηp2 = effect size, partial Eta square, Note: (*) trend towards statistical significance, *** Significance with p < 0.001.
Table 3. Results of rm ANOVA of cortisol [nmol/L] (N = 24) and α-amylase [U/mL] (N = 23) in saliva with the factors time (before and after product application) and samples (AC and PL).
Table 3. Results of rm ANOVA of cortisol [nmol/L] (N = 24) and α-amylase [U/mL] (N = 23) in saliva with the factors time (before and after product application) and samples (AC and PL).
EffectDFnumDFdenFp-Valueηp2
Cortisol
Time1232.0170.1690.081
Sample1230.0490.8260.002
Time×Sample1236.5830.017 *0.223
α-amylase
Time1220.0930.7630.004
Sample1220.0650.8010.003
Time×Sample1222.7430.1120.111
DFnum = degrees of freedom in numerator, DFden = degrees of freedom in denominator, F = noncentral F distribution, ηp2 = effect size, partial Eta square. Note: * Significance with p < 0.05.
Table 4. Effect of product application on alpha activity. A repeated-measures ANOVA with the factors time (before, after) and sample (AC, PL) was conducted (N = 24).
Table 4. Effect of product application on alpha activity. A repeated-measures ANOVA with the factors time (before, after) and sample (AC, PL) was conducted (N = 24).
EffectDFnumDFdenFp-Valueηp2
Time1232.2610.1460.090
Sample1230.0050.944<0.001
Time×Sample1233.3670.079 (*)0.128
DFnum = degrees of freedom in numerator, DFden = degrees of freedom in denominator, F = noncentral F distribution, ηp2 = effect size, partial Eta square. Note: (*) Trend towards statistical significance.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Springer, A.; Höckmeier, L.; Schicker, D.; Hettwer, S.; Freiherr, J. Measurement of Stress Relief during Scented Cosmetic Product Application Using a Mood Questionnaire, Stress Hormone Levels and Brain Activation. Cosmetics 2022, 9, 97. https://doi.org/10.3390/cosmetics9050097

AMA Style

Springer A, Höckmeier L, Schicker D, Hettwer S, Freiherr J. Measurement of Stress Relief during Scented Cosmetic Product Application Using a Mood Questionnaire, Stress Hormone Levels and Brain Activation. Cosmetics. 2022; 9(5):97. https://doi.org/10.3390/cosmetics9050097

Chicago/Turabian Style

Springer, Arielle, Laura Höckmeier, Doris Schicker, Stefan Hettwer, and Jessica Freiherr. 2022. "Measurement of Stress Relief during Scented Cosmetic Product Application Using a Mood Questionnaire, Stress Hormone Levels and Brain Activation" Cosmetics 9, no. 5: 97. https://doi.org/10.3390/cosmetics9050097

APA Style

Springer, A., Höckmeier, L., Schicker, D., Hettwer, S., & Freiherr, J. (2022). Measurement of Stress Relief during Scented Cosmetic Product Application Using a Mood Questionnaire, Stress Hormone Levels and Brain Activation. Cosmetics, 9(5), 97. https://doi.org/10.3390/cosmetics9050097

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop